AstraZeneca’s Benralizumab Asthma Chase Gets Underway
Executive Summary
Watch out GlaxoSmithKline and Teva: AstraZeneca's benralizumab has wind in its sails following a EU CHMP positive opinion for severe asthma. Approval in the US is also expected by year end.